RESMED INC — Director's Dealing 2020

Feb 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-02-10

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-10	ResMed Common Stock	M	6647	$43.63	Acquired	361347	Direct
2020-02-10	ResMed Common Stock	S	6647	$172.2074	Disposed	354700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-10	ResMed Common Stock Options	$43.63	M	6647	Disposed	2020-03-01	ResMed Common Stock (6647)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	8970	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $170.82 to $172.75. The price reported above reflects the weighted average sale price.

F3: Represents date options first became exercisable. Options vest 1/3 per year.